The Administration negotiated confidential deals on drug prices using HHS officials, involving major pharmaceutical companies.

The entities involved

• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59
• Pfizer →

  American multinational pharmaceutical and biotechnology corporation

  • Dave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Mon 05:00
  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
• Department of Health & Human Services →

  government department in the state of Victoria, Australia

  • The Trump administration utilized the Department of Health & Human Services for an AI tool.Mon 18:02
  • The FDA reviewed risks and loosened the label on testosterone replacement therapy (TRT) following an attempt by the Trump administration to reverse its decline.Mon 12:10

Related events

• Jim O'Neill was nominated to advise HHS on operations and questioned regarding drug pricing deals after succeeding as deputy secretary.Sep 17
• RFK Jr.'s appointment as HHS Secretary is creating pressure as Medicare price setting and Part D redesign impact the sales and operations of major pharmaceutical companies including Pfizer, Amgen, J&J, Merck, and Eli Lilly.Jun 8
• Trump promised drug discounts for low-income Americans and discussed Pfizer deals at a Dallas convention.Sep 17
• Pfizer and other companies are facing administration policy guidance regarding higher drug prices abroad in exchange for revenue sharing with HHS.Sep 20
• The discussion centers on the differing views regarding vaccines and how Albert Bourla is navigating the company through various market pivots.Aug 18